
TY  - JOUR
TI  - Abstracts for the 2019 Scandinavian Society of Anaesthesiology and Intensive Care Medicine Congress in Copenhagen
JO  - Acta Anaesthesiologica Scandinavica
JA  - Acta Anaesthesiol Scand
VL  - 63
IS  - 8
SN  - 0001-5172
UR  - https://doi.org/10.1111/aas.13442
DO  - doi:10.1111/aas.13442
SP  - e1
EP  - e48
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
VL  - 145
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2009.07639.x
DO  - doi:10.1111/j.1365-2141.2009.07639.x
SP  - 1
EP  - 88
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13961
DO  - doi:10.1111/all.13961
SP  - 376
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - ACVIM ABSTRACTS
JO  - Journal of Veterinary Internal Medicine
VL  - 10
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1996.tb02047.x
DO  - doi:10.1111/j.1939-1676.1996.tb02047.x
SP  - 143
EP  - 195
PY  - 1996
ER  - 

TY  - JOUR
AU  - Wang, Xue
AU  - Shen, Shichen
AU  - Rasam, Sailee Suryakant
AU  - Qu, Jun
TI  - MS1 ion current-based quantitative proteomics: A promising solution for reliable analysis of large biological cohorts
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 38
IS  - 6
SN  - 0277-7037
UR  - https://doi.org/10.1002/mas.21595
DO  - doi:10.1002/mas.21595
SP  - 461
EP  - 482
KW  - MS1 quantification
KW  - ion current-based proteomics
KW  - LC-MS
KW  - reproducible protein measurement
KW  - large cohorts
PY  - 2019
AB  - The rapidly-advancing field of pharmaceutical and clinical research calls for systematic, molecular-level characterization of complex biological systems. To this end, quantitative proteomics represents a powerful tool but an optimal solution for reliable large-cohort proteomics analysis, as frequently involved in pharmaceutical/clinical investigations, is urgently needed. Large-cohort analysis remains challenging owing to the deteriorating quantitative quality and snowballing missing data and false-positive discovery of altered proteins when sample size increases. MS1 ion current-based methods, which have become an important class of label-free quantification techniques during the past decade, show considerable potential to achieve reproducible protein measurements in large cohorts with high quantitative accuracy/precision. Nonetheless, in order to fully unleash this potential, several critical prerequisites should be met. Here we provide an overview of the rationale of MS1-based strategies and then important considerations for experimental and data processing techniques, with the emphasis on (i) efficient and reproducible sample preparation and LC separation; (ii) sensitive, selective and high-resolution MS detection; iii)accurate chromatographic alignment; (iv) sensitive and selective generation of quantitative features; and (v) optimal post-feature-generation data quality control. Prominent technical developments in these aspects are discussed. Finally, we reviewed applications of MS1-based strategy in disease mechanism studies, biomarker discovery, and pharmaceutical investigations.
ER  - 

TY  - JOUR
TI  - ASBMR 18th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 11
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650111202
DO  - doi:10.1002/jbmr.5650111202
SP  - S1
EP  - S500
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts of The Movement Disorder Society's Thirteenth International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 24
IS  - S1
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.22628
DO  - doi:10.1002/mds.22628
SP  - S1
EP  - S653
PY  - 2009
ER  - 

TY  - JOUR
TI  - Individual in Society
JO  - Journal of Intellectual Disability Research
VL  - 48
IS  - 4‐5
SN  - 0964-2633
UR  - https://doi.org/10.1111/j.1365-2788.2004.00612.x
DO  - doi:10.1111/j.1365-2788.2004.00612.x
SP  - 463
EP  - 485
PY  - 2004
ER  - 

TY  - JOUR
AU  - BRIGGS, C.
TI  - Quality counts: new parameters in blood cell counting
JO  - International Journal of Laboratory Hematology
VL  - 31
IS  - 3
SN  - 1751-5521
UR  - https://doi.org/10.1111/j.1751-553X.2009.01160.x
DO  - doi:10.1111/j.1751-553X.2009.01160.x
SP  - 277
EP  - 297
KW  - Blood cell analysers
KW  - External Quality Assessment
KW  - nucleated red blood cells
KW  - immature granulocytes
KW  - functional iron deficiency
PY  - 2009
AB  - Summary Recently several parameters have been introduced to the complete blood count such as nucleated red blood cells, immature granulocytes; immature reticulocyte fraction, immature platelet fraction and red cell fragments as well as new parameters for detection of functional iron deficiency. Leucocyte positional parameters, which may diagnose specific diseases (e.g. differentiate between abnormal lymphocytes in leukaemia and viral conditions and may also detect malarial infection) are now available. At this time they are only used for research; however, generally such parameters later become reportable. One manufacturer?s routine analyser allows measurement of cells by flow cytometry using monoclonal antibodies. Currently, there are no accredited external quality assessment schemes (EQAS) for these parameters. For a number of parameters, on some instruments, there is no internal quality control, which brings into question whether these parameters should be used for clinical decision making. Other more established parameters, such as mean platelet volume, red cell distribution width and the erythrocyte sedimentation rate do not have EQAS available. The UK National EQAS for General Haematology held a workshop earlier this year in 2008 to discuss these parameters. Participants were asked to provide a consensus opinion on which parameters are the most important for inclusion in future haematology EQAS.
ER  - 

TY  - JOUR
TI  - Abstracts of Papers to be Presented at American Association of Blood Banks. 50 Annual Meeting October 18–22, 1997
JO  - Transfusion
VL  - 37
IS  - S9
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1997.tb02797.x
DO  - doi:10.1111/j.1537-2995.1997.tb02797.x
SP  - 1s
EP  - 111s
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 112
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12601
DO  - doi:10.1111/vox.12601
SP  - 5
EP  - 191
PY  - 2017
ER  - 

TY  - JOUR
TI  - Past, Present and Future Insights into the Understanding and Treatment of Osteoarthritis: Molecular and Mechanical Approaches
JO  - International Journal of Experimental Pathology
VL  - 90
IS  - 1
SN  - 0959-9673
UR  - https://doi.org/10.1111/j.1365-2613.2008.00612.x
DO  - doi:10.1111/j.1365-2613.2008.00612.x
SP  - A30
EP  - A84
PY  - 2009
ER  - 

TY  - JOUR
TI  - Proceedings of the 28th annual meeting of the American Institute of Ultrasound in Medicine and the 12th annual meeting of the Society of Diagnostic Medical Sonographers.
JO  - Journal of Ultrasound in Medicine
VL  - 2
IS  - 10
SN  - 0278-4297
UR  - https://doi.org/10.7863/jum.1983.2.10.1
DO  - doi:10.7863/jum.1983.2.10.1
SP  - 1
EP  - 269
PY  - 1983
ER  - 

TY  - JOUR
TI  - Abstract Supplement 2019 ACR/ARP Annual Meeting
JO  - Arthritis & Rheumatology
JA  - Arthritis Rheumatol
VL  - 71
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.41108
DO  - doi:10.1002/art.41108
SP  - 1
EP  - 5420
PY  - 2019
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
AU  - Loera-Valencia, R.
AU  - Cedazo-Minguez, A.
AU  - Kenigsberg, P.A.
AU  - Page, G.
AU  - Duarte, A.I.
AU  - Giusti, P.
AU  - Zusso, M.
AU  - Robert, P.
AU  - Frisoni, G. B.
AU  - Cattaneo, A.
AU  - Zille, M.
AU  - Boltze, J.
AU  - Cartier, N.
AU  - Buee, L.
AU  - Johansson, G.
AU  - Winblad, B.
TI  - Current and emerging avenues for Alzheimer's disease drug targets
JO  - Journal of Internal Medicine
JA  - J Intern Med
VL  - 286
IS  - 4
SN  - 0954-6820
UR  - https://doi.org/10.1111/joim.12959
DO  - doi:10.1111/joim.12959
SP  - 398
EP  - 437
KW  - AD gene therapy
KW  - AD molecular targets
KW  - AD therapeutics
KW  - alzheimer´s disease
KW  - amyloid beta therapies
KW  - Tau therapies
PY  - 2019
AB  - Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its progression. The most important feature of the disease is neuronal death and loss of cognitive functions, caused probably from several pathological processes in the brain. The main neuropathological features of AD are widely described as amyloid beta (A?) plaques and neurofibrillary tangles of the aggregated protein tau, which contribute to the disease. Nevertheless, AD brains suffer from a variety of alterations in function, such as energy metabolism, inflammation and synaptic activity. The latest decades have seen an explosion of genes and molecules that can be employed as targets aiming to improve brain physiology, which can result in preventive strategies for AD. Moreover, therapeutics using these targets can help AD brains to sustain function during the development of AD pathology. Here, we review broadly recent information for potential targets that can modify AD through diverse pharmacological and nonpharmacological approaches including gene therapy. We propose that AD could be tackled not only using combination therapies including A? and tau, but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, epigenetics, neurovascular junction and blood?brain barrier targets that have been studied recently. We also make a case for the role of gut microbiota in AD. Our hope is to promote the continuing research of diverse targets affecting AD and promote diverse targeting as a near-future strategy.
ER  - 

AU  - Sterling, J. C.
C7  - pp. 1-81
TI  - Virus Infections
SN  - 9781405161695
UR  - https://doi.org/10.1002/9781444317633.ch33
DO  - doi:10.1002/9781444317633.ch33
SP  - 1-81
KW  - general pathology of viruses - entry of virion into cell by endocytosis or phagocytosis
KW  - poxviruses, producing eosinophilic inclusion bodies, Guanieri bodies
KW  - herpes viruses, detectable intranuclear inclusion bodies
KW  - polyomavirus- Merkel cell carcinoma
KW  - human papillomaviruses (HPV) - upper stratum spinosum and stratum granulosum
KW  - hepatitis viruses and Gianotti–Crosti syndrome
KW  - Rubella - rubivirus genus Togaviridae
KW  - picornaviruses, enteroviruses—poliomyelitis
KW  - vesicular stomatitis virus-intranuclear inclusions
KW  - myxoviruses and related RNA viruses - paramyxovirus and morbillivirus
PY  - 2019
AB  - Summary This chapter contains sections titled: Poxviruses Herpesviruses Polyomavirus Human papillomaviruses (HPV) Hepatitis viruses Parvoviruses Retroviruses Viral insect-borne and haemorrhagic fevers Rubella [1] Picornaviruses Vesicular stomatitis virus Myxoviruses and related RNA viruses Other cutaneous problems associated with viral infections References
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
SN  - 9781405161695
UR  - https://doi.org/10.1002/eji.200990224
DO  - doi:10.1002/eji.200990224
SP  - S55
EP  - S279
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - 21st IEC Proceedings
JO  - Epilepsia
VL  - 36
IS  - s3
SN  - 9781405161695
UR  - https://doi.org/10.1111/j.1528-1157.1995.tb01719.x
DO  - doi:10.1111/j.1528-1157.1995.tb01719.x
SP  - S1
EP  - S275
PY  - 1995
ER  - 

TY  - JOUR
TI  - Scandinavian Congress of Physiology and Pharmacology, Odense, Denmark, October 11-14, 2003
JO  - Acta Physiologica Scandinavica
VL  - 181
IS  - 1
SN  - 9781405161695
UR  - https://doi.org/10.1111/j.1365-201X.2004.1268.x
DO  - doi:10.1111/j.1365-201X.2004.1268.x
SP  - 43
EP  - 163
PY  - 2004
ER  - 

TY  - JOUR
TI  - American Epilepsy Society Proceedings
JO  - Epilepsia
VL  - 36
IS  - s4
SN  - 9781405161695
UR  - https://doi.org/10.1111/j.1528-1157.1995.tb01720.x
DO  - doi:10.1111/j.1528-1157.1995.tb01720.x
SP  - S1
EP  - S172
PY  - 1995
ER  - 
